University Of Washington
Clinical trials sponsored by University Of Washington, explained in plain language.
-
Immune drug shows promise for untreated lymphoma patients
Disease control TerminatedThis study tested the drug pembrolizumab in 9 people with untreated B-cell non-Hodgkin lymphoma (follicular or marginal zone lymphoma). The goal was to see if this immunotherapy could shrink tumors by helping the immune system attack cancer cells. The trial was stopped early, so …
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New programs aim to ease the emotional toll of advanced cancer on parents and kids
Symptom relief TerminatedThis study looked at two educational programs for parents with late-stage cancer who have children between 5 and 17 years old. The goal was to help parents feel more confident talking with their child about cancer and improve the parent-child relationship. The programs aimed to r…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Apr 30, 2026 15:49 UTC
-
Can genetic testing help men with spread prostate cancer?
Knowledge-focused TerminatedThis study offered free genetic testing to 799 men whose prostate cancer had spread. Researchers looked for inherited gene changes linked to cancer risk and asked participants about their thoughts on testing. The goal was to learn if this approach works and to share results with …
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC
-
New scan could help doctors plan better liver cancer treatment
Knowledge-focused TerminatedThis study tested a special type of scan (SPECT/CT) that uses a safe radioactive tracer to measure how well the liver is working in people with liver cancer. The goal was to see if the scan could track changes in liver function before, during, and after radiation or surgery. Abou…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC